Analgesic Efficacy of Sequential Rapid Versus Slow Intrathecal Injection Of Dexmedetomidine Followed by of Hyperbaric Bupivacaine in Inguinal Hernia Repair Surgery - Trial NCT06253260
Access comprehensive clinical trial information for NCT06253260 through Pure Global AI's free database. This phase not specified trial is sponsored by Cairo University and is currently Recruiting. The study focuses on Postoperative Pain. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Analgesic Efficacy of Sequential Rapid Intrathecal Injection Of Dexmedetomidine Followed by Slow Injection of Hyperbaric Bupivacaine Injection in Patients Undergoing Unilateral Inguinal Hernia Repair
Interventional
drug
Sponsor & Location
Cairo University
Timeline & Enrollment
N/A
Feb 15, 2024
May 20, 2024
Primary Outcome
Duration of postoperative analgesia
Summary
Analgesic Efficacy of Sequential Rapid Intrathecal Injection Of Dexmedetomidine Followed by
 Slow Injection of Hyperbaric Bupivacaine Versus Sequential Slow Injection of Both Drugs in
 Patients Undergoing Unilateral Inguinal Hernia Repair Surgery
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06253260
Non-Device Trial